CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), a leader in artificial intelligence-driven precision cardiovascular medicine tests, today announced the American Medical ...

Please provide your email address to receive an email when new articles are posted on . A novel genetic test may provide clues to what caused a person’s sudden cardiac death. Testing can then be ...

A precision cardiovascular medicine company’s innovative AI-driven epigenetic-genetic blood tests will soon be available in one of the nation’s largest retailers. Beginning Q2 2024, Cardio Diagnostics ...

Genetic testing is moving from predicting heart attacks years down the line to flagging dangerous heart rhythms before they ever appear on an electrocardiogram. Instead of waiting for symptoms, ...

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), a leader in artificial intelligence-driven precision cardiovascular medicine tests, today announced the publication of its ...

The common genetic heart condition under the lens is hypertrophic cardiomyopathy (HCM). The problem is that there is no cure ...

A recent study found that negative autopsy/sudden unexplained death (SUD) constituted the most common observation in sudden ...

Cardio Diagnostics will place its epigenetic-genetic blood tests for coronary heart disease (CHD) into Walmart in partnership with Illinois primary care network Family Medicine Specialists (FMS). The ...

Fourth generation Coloradan Nate Drinkwine didn't find out that he had the heart condition hypertrophic cardiomyopathy until his mid-20s. Fourth generation Coloradan Nate Drinkwine didn't find out ...